共 50 条
- [21] A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II TrialCLINICAL CANCER RESEARCH, 2016, 22 (24) : 6010 - 6020Yanagita, MasahikoRedig, Amanda J.Paweletz, Cloud P.Dahlberg, Suzanne E.O'Connell, AllisonFeeney, NoraTaibi, MyriamBoucher, DavidOxnard, Geoffrey R.Johnson, Bruce E.Costa, Daniel B.Jackman, David M.Janne, Pasi A.
- [22] Cell-free DNA from EGFR-mutated lung cancer cells treated with EGFR-TKIs engages in innate immune signaling pathwaysCANCER SCIENCE, 2022, 113 : 835 - 835Shiiya, AkihikoNoguchi, TakuroAriga, ShinOhhara, YoshihitoShimizu, YasushiKinoshita, IchiroAkita, Hirotoshi
- [23] Noninvasive, Highly Specific Detection of T790M-Mediated Acquired Resistance in EGFR Mutant NSCLC Using a Novel Droplet Digital PCR (ddPCR)-Based Cell-free Plasma DNA (cfDNA) AssayINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S71 - S71Sacher, A. G.Mach, S.Messineo, M.Jackman, D. M.Jaenne, P. A.Paweletz, C. P.Oxnard, G. R.
- [24] Detection of EGFR Mutations in Circulating Cell-Free DNA (cfDNA) from Plasma Samples of Patients with Non-Small Cell Lung Cancer Using the Oncomine Lung cfDNA AssayJOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (03): : S18 - S19Anand, S.Matharu, B.Lu, W.Dimastrogiovanni, D.Butler, C.Verrissimo, T.Harden, S.Gilligan, D.Jones, A.Scott, M.Liu, H.
- [25] Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significanceONCOLOGY LETTERS, 2017, 13 (06) : 4549 - 4557Ni, JianjiaoWeng, LinqianLiu, YiSun, ZhaoBai, ChunmeiWang, Yingyi
- [26] Re-visiting EGFR amplification as a target for anti-EGFR therapy: Analysis of cell-free circulating tumor DNA in patients with diverse cancers.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Kato, ShumeiOkamura, RyosukeMareboina, ManvitaLee, SuzannaGoodman, AaronPatel, Sandip PravinFanta, Paul T.Schwab, Richard B.Sicklick, Jason K.Raymond, Victoria M.Lanman, Richard B.Kurzrock, Razelle
- [27] Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNAONCOTARGET, 2017, 8 (08) : 13611 - 13619Del Re, MarziaTiseo, MarcelloBordi, PaolaD'Incecco, ArmidaCamerini, AndreaPetrini, IacopoLucchesi, MaurizioInno, AlessandroSpada, DanieleVasile, EnricoCiti, ValentinaMalpeli, GiorgioTesta, EnricaGori, StefaniaFalcone, AlfredoAmoroso, DomenicoChella, AntonioCappuzzo, FedericoArdizzoni, AndreaScarpa, AldoDanesi, Romano
- [28] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitorsCancer Chemotherapy and Pharmacology, 2021, 87 : 269 - 276R. B. VerheijenT. T. van DuijlM. M. van den HeuvelD. VessiesM. MullerJ. H. BeijnenJ. M. JanssenJ. H. M. SchellensN. SteeghsD. van den BroekA. D. R. Huitema
- [29] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitorsCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (02) : 269 - 276Verheijen, R. B.van Duijl, T. T.van den Heuvel, M. M.Vessies, D.Muller, M.Beijnen, J. H.Janssen, J. M.Schellens, J. H. M.Steeghs, N.van den Broek, D.Huitema, A. D. R.
- [30] Detection of EGFR mutations into circulating tumor cells of patients with NSCLC by coupling cell-size based enrichment method and multiplex ddPCRCLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 213 - 213Denis, J. A.Benali-Furet, N.Guillerm, E.Gobert, A.Znaty, A.Uzan, G.Henaff, D.Fina, F.Coulet, F.Lacorte, J. M.